While the genomic analysis from the patient’s endometrial tumor suggests the pathogenic role of the POLD1 p.D402N mutation, it is unclear if the observed increased tumor mutation burden and SBS10d mutational signature are directly caused by the patient’s germline p.D402N. The gene discussed is POLD1; the disease is neoplasm.